You are here

Home » Content

Sebepsiz kişilik değişiklikleri ile başlayan glioblastome multiforme: Bir olgu sunumu

Glioblastome multiforme begin with personality changes for no apparent reason: a case report

Journal Name:

  • Abant Tıp Dergisi

Publication Year:

  • 2012
DOI: 
http://dx.doi.org/10.5505/abantmedj.2012.43534

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
In a 74-year-old female patient with complaints of per-sonality disorder and headache, magnetic resonance imaging revealed bifrontal mass. Tumor resection was performed. The pathology report was defined glioblas-tome multiforme. Patient follow-up clinical findings were normal. The presence of a cranial mass in patients pre-senting with personality changes for no reason must be considered and investigated appropriate.
Bookmark/Search this post with
Abstract (Original Language): 
Kişilik bozukluğu ve baş ağrısı şikayetleri bulunan 74 yaşında bayan hastanın magnetik rezonans görüntülemesinde bif-rontal kitle saptandı. Tümör rezeksiyonu yapıldı. Patoloji sonucu glioblastome multiforme geldi. Hastanın takiplerin-de klinik bulguları normaldi. Sebepsiz kişilik değişikliği ile başvuran hastalarda kranial bir kitlenin varlığı düşünülerek araştırılma yapılması uygundur.
FULL TEXT (PDF): 
PDF icon arastirmax-sebepsiz-kisilik-degisiklikleri-ile-baslayan-glioblastome-multiforme-bir-olgu-sunumu.pdf
  • 1
23-25
  • Turkish

REFERENCES

References: 

1. Tolgay E, Bahar A, Yurtoğulları Ş, Karlı N, Erer S, Turan F ve ark. Multisentrik Glioblastoma Multiforme Olgusu. Türk Nörol Derg 2008; 14: 272 – 276.
2. George M, Liangge H. Glioblastoma Multiforme. Brigham Radiology 1994.
3. Vougiouklakis T, Mitselou A, Agnantis NJ. Sudden death due to primary intracranial neoplasms. A forensic autopsy study. Anticancer Res. 2006;26:2463-6.
4. Matschke J, Tsokos M. Sudden Unexpected Death due to Undiagnosed Glioblastoma: Report of three cases and Review of the Literature. Acta Neurochir Suppl 2003;86:507-11.
5. Frederiks J. Transient global amnesia. Clin Neurol Neurosurg, 1993;95:265-83.
6. Parlayan ET. Geçici global amnezi ve demansiyel bulgular ile başlayan glioblastome multiforme olgusu. Klinik Psikiyatri 2010;13:209-214.
7. Levin VA, Sheline PH, Gutin PH: Neoplasms of central nervous system, in de Vita, Helman VTS, Rosenberg SA (eds): Cancer. Principles and Practice of Onkology, vol 2, 3rd ed. Philadelp-hia: Lippincott, 1989:1557-1612
8. Eroğlu C, Soyuer S, Yıldız OG, Özkan M, Menkü A, Orhan O ve ark. Glioblastoma multiforme’li olgularda postoperatif radyo-terapi ile eş zamanl temozolomide adjuvan temozolomid te-davesinin tedavi sonuçlarına katkısı UHOD 2008; 18: 65-73.
9. Reni M, Cozzarini C, Ferreri AJM, Ceresoli GL, Galli L, Bianchi A, et al. A retrospective analysis of postradiation chemotherapy in 133 patients with glioblastoma multiforme. Cancer Invest 2000; 18: 510-515.
10. Brada M, Sharpe G, Rajan B, Britton J, Wilkins PR, Guerrero D, et al. Modifying radical radiotherapy in high grade gliomas; Shortening the treatment time through acceleration. Int J Ra-diat Oncol Biol Phys 1999; 43: 287-292.
11. Dere F. Nöroanatomi. 1. Baskı, Adana: Ç.Ü. Basımevi, 1990; 10-113
12. Levin A, Leibel SA, Gutın PH. Neoplasms of the Central Ner-vous. De Vita VT, Hellman S, Rosenberg SA Cancer Principles and Practice of Oncology. 5th ED., Philadelphia: J.B Lippincot-Raven Publıshers, 1997:2022-2083.
13. Weingart J, Brem H. Brain Tumors and Cancers of the Central Nervous System. Neıderhuber JE. Current Therapy. Fhırst ED., Decker: Mosby- Year Book Inc, 1993: 538-546.
14. Karlsson UL, Leibel SA, Wallner K, DavisLW, Brady LW, Brain in: Principles and Practise of Radiation Oncology. (eds) : Perez CA, Brady LW ,J.B Lippincot Company Philadelphia:1992, ch23: 513-563
15. Karlsson UL, Leibel SA, Wallner K, DavisLW, Brady LW. Primary intracranial Neoplasms. Perez CA, Brady LW. Principles and Practise of Radiation Oncology. Third ED., Philadelphia: J.B Lippincot Company 1998 :777-822.
16. Demir MK, Hakan T, Okan Akıncı, Berkman Z. Primer serebellar glioblastoma multiforme. Diagn Interv Radiol 2005; 11:83-86
17. Mayadağlı A, Tezcan Y, Uyanoğlu A, Aksakal Ö, Kızılkaya O, Erkal H ve ark. Konvansiyonel eksternal radyoterapi uygulanan glioblastoma multiforme tanılı 40 hastanın irdelenmesi. Genel Tıp Dergisi 1997 ;7 :121-3.
18. Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, et al. Comparison of post-operative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 1983; 52: 997-1007.
19. Kristiansen K, Hagen S, Kollevold T, Torvik A, Holme I, Nes-bakken R, et al. Combined modality therapy of operated ast-rocytomas Grade III and IV. Confirmation of the value of pos-toperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandi-navian Glioblastoma Study group. Cancer 1981; 47: 649-652.
20. Buatti JM, Marcus RB, Mendenhall WM, Friedman WA, Bova FJ. Accelerated hyperfractionated radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys 1996; 34: 785-792.
21. Fulton DS, Urtasun RC, Shin KH, Geggie PH, Thomas H, Muller PJ, et al. Misonidasole combined with hyperfractionation in the management of malignant glioma. Int J Radiat Oncol Biol Phys 1984; 10: 1709-1712.
22. Keim H, Potthoff PC, Schmidt K, Schiebusch M, Neiss A, Trott KR. Survival and quality of life after continuous accelerated radiotherapy of glioblastomas. Radiother Oncol 1987; 9: 21-26.

Thank you for copying data from http://www.arastirmax.com